Article metrics

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study

 

Online download statistics by month:

Online download statistics by month: May 2021 to June 2021

AbstractFullPdf
May 202111251106418
Jun 2021684678166
Total18091784584